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Abstract The genetic underpinnings of heart rate reg-
ulation are only poorly understood. In search for genetic
regulators of cardiac pacemaker activity, we isolated in a
large-scale mutagenesis screen the embryonic lethal,
recessive zebrafish mutant schneckentempo (ste). Homo-
zygous ste mutants exhibit a severely reduced resting heart
rate with normal atrio-ventricular conduction and con-
tractile function. External electrical pacing reveals that
defective excitation generation in cardiac pacemaker cells
underlies bradycardia in ste-/- mutants. By positional
cloning and gene knock-down analysis we find that loss of
dihydrolipoyl succinyltransferase (DLST) function causes
the ste phenotype. The mitochondrial enzyme DLST is an
essential player in the citric acid cycle that warrants proper
adenosine-tri-phosphate (ATP) production. Accordingly,
ATP levels are significantly diminished in ste-/- mutant
embryos, suggesting that limited energy supply accounts
for reduced cardiac pacemaker activity in ste-/- mutants.
We demonstrate here for the first time that the mitochon-
drial enzyme DLST plays an essential role in the mod-
ulation of the vertebrate heart rate by controlling ATP
production in the heart.
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Introduction
Diseases of cardiac pacemaker cells such as the sick sinus
syndrome are the most common indications for cardiac
pacemaker implantations [12, 27]. However, little is known
about the genetic underpinnings of cardiac pacemaker
function in vertebrates. Genetic studies in humans have
demonstrated a significant contribution of genetic factors in
heart rate regulation [11, 12, 38]. For instance, it was found
that autosomal recessive mutations of the sodium-channel
SCN5A lead to familial sick sinus syndrome [4]. Further-
more, a combined genome-wide association study that
included data from 181,171 individuals recently led to the
identification of 14 distinct genomic regions that sig-
nificantly impact on heart rate regulation [12]. Interestingly,
in these regions both, genes already known to be involved in
heart rate regulation such as the hyperpolarization-activated
cyclic nucleotide-gated cation channel 4 (HCN4), but also
several novel modifier genes are located [12].
In recent years, large-scale forward genetic screens in
zebrafish helped to dissect novel genetic underpinnings of
cardiac rhythm control [10, 20, 31, 34, 42]. For instance,
characterization of the zebrafish mutants island beat and
tremblor revealed an essential role of the L-type calcium
channel alpha 1 subunit and the sodium–calcium exchanger
NCX1h in the pathogenesis of atrial and ventricular
fibrillation, respectively [15, 24, 37]. Furthermore, char-
acterization of a bradycardic zebrafish mutant and gene
knock-down studies recently revealed an essential role of
Shox2-Islet1 signaling in the control of cardiac pacemaker
activity [21].
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In search for novel regulators of basal heart rate we
dissected here the genetic cause of the embryonic-lethal
recessive ethylnitrosourea (ENU)-induced bradycardic
zebrafish mutant schneckentempo (ste), and find that
DLST, a mitochondrial enzyme that acts within the citric
acid cycle to warrant ATP production, is essential for
cardiac pacemaker cells.
Materials and methods
Zebrafish (Danio rerio) were bred and maintained at
28.5 C as described by Westerfield [47]. Pictures and
movies were recorded at 48 h post-fertilization (hpf) and
72 hpf. To inhibit pigmentation 0.003 % 1-phenyl-2-
thiourea was added to the regular embryo medium E3
(5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM
MgSO4 dissolved in water). Heart rate was counted at 48,
72, 96 and 120 hpf at room temperature.
We measured fractional shortening by videomicroscopy
at room temperature and compared the diameters of the
ventricle at the end of contraction (systole) and relaxation
(diastole) as described before [31].
DNA from 48 ste-/- mutant and 48 wild-type embryos
was pooled and bulked segregation analysis was performed
as described before [33]. The critical genomic interval for
ste was defined by genotyping 613 mutant embryos for
polymorphic markers in the area. RNA from ste-/- mutant
and wild-type embryos was isolated using TRIZOL
Reagent (Life Technologies) and reverse transcribed.
cDNA of a total of 30 mutant and wild-type embryos was
sequenced. Genomic DNA from ten ste-/- mutant and ten
wild-type embryos was sequenced around the point
mutation.
Quantitative real-time PCR was carried out according to
standard protocols with the SYBR-Green method (Bio-
Rad) and an Eppendorf Realplex-2 cycler. cDNA was
generated from RNA of 72 hpf homozygous ste mutant and
sibling embryos using oligo(dT) primer and SuperScript III
reverse transcriptase (Invitrogen).
For all Morpholino-modified antisense oligonucleotide
injection procedures, the TE wild-type strain was used.
Morpholino-modified antisense oligonucleotides (MO;
Gene Tools, LLC) were directed against the translational
start site (50-TCAGACAGCGGGAATGACACAACAT-30)
of zebrafish DLST (MO-DLST-start), the splice donor site
of exon 5/intron 5 (50-CATGTTGCCTTCTTACCTTTCTC
CC-30) of zebrafish DLST on chromosome 17 (MO-DLST-
splice), the splice donor site exon 3/intron 3 (50-ACTG
GATGTCAGATCGGTACCTTAA-30) of DLDH on chro-
mosome 25 (MO-DLDH-splice), the splice donor site exon
5/intron 5 of zebrafish OGDH a (50-AGACCTTCAAATCT
TCTACCTGTGC-30) on chromosome 8 (MO-OGDHa-
splice) and the splice donor site exon 7/intron 7 of zebrafish
OGDH b (50-TTCTTGTTGTCCTGACTTACCTCTA-30)
on chromosome 10 (MO-OGDHb-splice). DLST, OGDH
and DLDH Morpholino-modified antisense oligonu-
cleotides or a standard control Morpholino (MO-control)
were microinjected into zebrafish embryos up to the 4-cell
stage.
For histology, embryos were fixed with 4 %
paraformaldehyde and embedded in JB-4 (Polysciences,
Inc). Then, 5-lm sections were cut, dried, and samples
were stained with hematoxylin and eosin. Transmission
electron micrographs (TEM) were obtained essentially as
described previously [37]. Whole-mount antisense RNA
in situ hybridization was carried out as described pre-
viously [22, 23] using a digoxigenin-labeled antisense
probe for zebrafish DLST.
Calcium imaging was performed as described before
[28]. Wild-type and ste-/- mutant embryos were injected
with 1 nl of a 250 lM stock solution of calcium green-1
dextran (Molecular Probes) at the one-cell stage. At 72 hpf
videos were recorded with a Proxitronic (Proxivision)
camera at 29.97 frames per second. Relative fluorescence
of the atrium and ventricle were analyzed with custom-
made software [31].
Electrical stimuli were applied by a pacemaker
(PACE100H; Osypka Medical GmbH). Patch clamp pip-
ettes filled with 3 M potassium chloride with a resistance
of 2–10 MX were used as cathode. As described before
[31, 37], this electrode was approached to either the atrium
or ventricle with a micromanipulator under microscopic
control. The heart chambers were stimulated at different
frequencies (80–150/min), applying 1–12 V.
Sodiumfluoroacetate (SFA) (FCH2CO2Na) was added at
a concentration of 0.067 or 0.2 mg/ml to the medium of
dechorionated wild-type zebrafish at 24 hpf and exchanged
every 24 h. SFA blocks aconitate hydratase thereby in-
hibiting the citric acid cycle [36].
2,4-Dinitrophenol (DNP) (Sigma Aldrich) was added at
a concentration of 10 lM to the medium of dechorionated
wild-type zebrafish embryos at 48 hpf. 2,4-Dinitrophenol
uncouples the respiratory chain reaction from ATP pro-
duction [8, 39, 46]. At high concentrations it is known to
decrease ATP production [9, 46], whereas at lower con-
centrations predominantly reactive oxygen species (ROS)
production is influenced [8, 39].
Idebenone (IDB, Sigma Aldrich) proved to act antiox-
idative against ROS and to promote mitochondrial function
and ATP production after acute exposure by increasing the
effectiveness of the respiratory chain reaction [6, 19]. Ze-
brafish embryos were incubated at 48 hpf at a concentra-
tion of 0.3 lM dissolved in ethanol.
ATP content was measured with a luciferase-based as-
say (ATP Determination Kit A22066, Invitrogen, Life
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Technologies Corporation) with recombinant firefly lu-
ciferase and D-luciferin. Zebrafish embryos were me-
chanically lysed and luminescence was immediately
quantified by Berthold Luminometer Lumat LB 9501. The
ATP content was calculated by creating an ATP-lumines-
cence standard curve in Microsoft Excel.
Data of protein expression was obtained from the pro-
tein expression database MOPED (http://www.protein
spire.org/MOPED/mopedviews/proteinExpressionData
base.jsf) and PaxDb (http://www.pax-db.org).
All results are depicted as arithmetic mean ± standard
error of mean from at least two independent experiments.
Figures were created with Microsoft Excel. Area measure-
ments in TEM were conducted with ArchiCAD (Graphisoft).
Statistical analysis was performed in Graph Pad Prism.
Comparisons between experimental groups were per-
formed using t test. Differences are considered significant
at a p \ 0.05 significance level and marked with ‘‘*’’, very
significant with p \ 0.01 are labeled ‘‘**’’ and extremely
significant with p \ 0.001 are labeled ‘‘***’’.
Results
Zebrafish mutant schneckentempo exhibits bradycardia
In search for genetic modulators of the vertebrate heart
rate, we isolated in a large-scale ENU-mutagenesis screen
(Tu¨bingen 2000) the embryonic-lethal zebrafish mutant
line schneckentempo (ste), which displays a severely
reduced resting heart rate, so-called bradycardia. Besides
their reduced heart rate, ste-/- mutant zebrafish embryos
exhibit decreased motility both spontaneously and in
response to touch.
Up to 72 h post-fertilization (hpf), ste-/- mutant
embryos are indistinguishable from their wild-type litter-
mates in regard to cardiac structure and function. However,
at 72 hpf ste-/- mutant embryos display severe brady-
cardia with a heart rate of 81 ± 4.7 beats per minute (bpm)
compared to 143 ± 4.7 bpm in wild-type siblings (n = 16,
p \ 0.0001) measured at room temperature. During further
development the heart rate of ste-/- mutant embryos even
further decreases at 96 hpf to 73 ± 2.3 bpm compared to
167 ± 5.7 bpm (n = 16, p \ 0.0001) and to
68 ± 6.5 bpm compared to 163 ± 3.9 bpm in wild-type
siblings at 120 hpf (n = 16, p \ 0.0001) (Fig. 1c).
Although the heart rate is significantly reduced in ste-/-
mutants, similar to the situation in wild-types, ste-/- hearts
contract regularly and sequentially, whereby each atrial
contraction is followed by a ventricular contraction, indi-
cating unaffected atrio-ventricular conduction in ste-/-
hearts. Similarly, cardiac contractility is not reduced in
homozygous ste mutants. As shown in Fig. 1d ventricular
fractional shortening is 53 ± 2.2 % in ste-/- mutants and
55 ± 3.1 % in wild-type ste siblings at 72 hpf (n = 5,
p = 0.7096), a time point where severe bradycardia is
already manifest in ste-/- mutant embryos.
The ste locus encodes for zebrafish dihydrolipoyl
succinyltransferase
To identify the mutation causing the recessive ste-/-
mutant phenotype, we performed a genome-wide study of
microsatellite marker segregation and linked ste to zebra-
fish chromosome 17. Recombination analysis of 1,226
ste-/- mutant embryos restricted ste-/- to a genomic
interval flanked by the microsatellite markers z13385 and
z381. Genetic fine-mapping further narrowed down the ste
locus to the two bacterial artificial chromosomes (BAC)
BX005229 and AL935141, and finally to two open reading
frames encoding proteins highly homologous to human
prospero-related homeobox 2 (prox2) and dihydrolipoyl
succinyltransferase (DLST) (Fig. 2a). To identify the site
of the ENU-induced mutation in ste, we sequenced the
entire zebrafish coding sequence of the 2 genes zprox2 and
zdlst from wild-type and ste-/- mutant genomic DNA and
identified the ste mutation to be a guanine to adenine
nucleotide transition in the splice donor site of intron 5 of
the zdlst gene (ENSDARG00000014230). Zdlst cDNA
analysis of ste-/- mutants reveals that upstream of the
mutated splice donor site an alternative splice site is used,
resulting in partial exon skipping with deletion of 11
nucleotides (Fig. 2b). The consecutive reading frame shift
generates an early stop codon and is predicted to cause
premature termination of translation of dlst in ste-/-
mutants (Supplementary Fig. 1). Next, to evaluate if the ste
mutation impairs RNA stability, we quantified RNA levels
by whole-mount RNA antisense in situ staining and qRT-
PCR and find reduced levels of dlst RNA down to
10.7 ± 5.3 % in ste-/- mutants (n = 4, p = 0.0414) in
comparison to wild-type ste siblings (Fig. 2e).
DLST is an essential component of the a-ketoglutarate
dehydrogenase complex of the citric acid cycle and is ex-
pressed ubiquitously in mammals with pronounced levels
in the liver, the kidneys, the central nervous system and the
heart (databases for protein expression MOPED and
PaxDb). As shown in Fig. 2c, we find dlst RNA to be
ubiquitously distributed in wild-type zebrafish embryos,
with enhanced levels in the heart, skeletal muscle and
pectoral fins. Zebrafish DLST is highly homologous to
human DLST with a 74 % overall amino acid identity
(Supplementary Fig. 1). The ste mutation resides within
the NH2-terminal lipoyl domain of DLST and hence the
COOH-terminal catalytic domain of DLST is predicted not
to be translated in ste-/- mutants leading to loss of DLST
function.
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To validate that loss of DLST function indeed is
responsible for the ste phenotype, we inactivated zdlst by
Morpholino-modified antisense oligonucleotide mediated
gene knock-down, targeting either the translation initiation
site (MO-DLSTstart) or the splice donor site of the exon
5/intron 5 boundary (MO-DLSTsplice) of zdlst, where the
ste mutation resides. Injection of 4.2 ng MO-DLSTsplice
into wild-type zebrafish embryos leads to bradycardia
(89 ± 4 bpm) in 72 hpf embryos, whereas MO-control
injected embryos exhibit normal heart rates of
132 ± 1 bpm (n = 14, p \ 0.0001, Fig. 3d). Similar
results were obtained by injection of 21.2 ng of MO-
DLSTstart (heart rate at 72 hpf in MO-DLSTstart mor-
phants 92 ± 6 bpm; in controls 139 ± 2 bpm; n = 10,
p \ 0.0001), indicating that the ste mutation leads to
complete loss of zDLST function.
Loss of DLST function induces mitochondrial
degeneration in schneckentempo mutants
Dihydrolipoyl succinyltransferase is known to localize to
the mitochondrial matrix where it catalyzes within the a-
ketoglutarate dehydrogenase complex the citric acid cycle.
Loss of mitochondrial enzyme function is often accom-
panied by morphological alterations of mitochondria [1, 7,
25, 45]. To determine if this is also the case in DLST-
deficient ste-/- mutant zebrafish, we analyzed the mito-
chondrial ultrastructure in ventricular and atrial cardio-
myocytes of ste-/- mutants by transmission electron
microscopy (TEM). We find in ste-/- hearts large vacuoles
either in the vicinity of mitochondria or within mitochon-
dria. Their position is shifted from the interfibrillar to the
sub-sarcolemmal and perinuclear regions as seen in other
mitochondriopathies involving the heart [25]. Furthermore,
similar to other mitochondriopathies [25] mitochondrial
density is altered in ste-/- myocardium compared to wild-
type embryos (2.20 ± 0.29 % in ste-/- versus
1.01 ± 0.20 % in wild-type, n = 100, p = 0.001) and the
average size of mitochondria is significantly enlarged
(0.67 ± 0.072 lm2 in ste-/- versus 0.35 ± 0.027 lm2 in
wild types, n = 100, p \ 0.0001). In addition, as shown in
Fig. 3 mitochondria in ste-/- mutant hearts are pleo-
morphic, irregularly shaped and contain reduced numbers
of cristae (4.8 ± 0.76 in ste-/- and 15.2 ± 1.7 in wild-
type, n = 15, p = 0.0001). Similar changes on mitochon-
drial morphology could be observed in other ste-/- mutant
tissues such as the skeletal muscle (Fig. 3g, h).
Resting heart rate depends on the citric acid cycle
The citric acid cycle guarantees energy production by
metabolizing amino acids, fatty acids and carbon hydrates
Fig. 1 Effects of the ste mutation on cardiac function. a, b Lateral
view of wild-type (wt) (a) and ste-/- mutant (b) embryos at 72 h
post-fertilization (hpf). ste-/- mutants (b) develop blood congestion
at the cardiac inflow tract and a pericardial edema. c Heart rate at
different time points in ste-/- mutants (red) and wild-type littermates
(blue). Bradycardia in ste-/- mutants starts at 48 hpf and becomes
more severe during further embryonic development. d Ventricular
fractional shortening is unaffected in ste-/- mutants compared to
wild-type littermates at 72 hpf (53 ± 2.2 vs. 55 ± 3.1 %, n = 5,
p = 0.7096), 96 hpf (58 ± 3.2 vs. 57 ± 1.9 %, n = 5, p = 0.7956)
and 120 hpf (59 ± 1.9 vs. 61 ± 1.8 %, n = 5, p = 0.5586)
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[13]. Within the citric acid cycle, the a-ketoglutarate
dehydrogenase complex is the rate-limiting component
[30] and consists of three subunits: E1—oxoglutarate
dehydrogenase (OGDH), E2—dihydrolipoyl succinyl-
transferase (DLST) and E3—dihydrolipoyl dehydrogenase
(DLDH) [5, 18, 26]. To evaluate if the effect of DLST on
zebrafish heart rate is mainly mediated via the a-ketoglu-
tarate dehydrogenase complex, we inactivated the other
subunits of this complex by Morpholino-modified antisense
oligonucleotide mediated knock-down in zebrafish. To do
so, we first identified the zebrafish subunit E1 and subunit
E3 orthologous sequences and designed corresponding
Fig. 2 ste encodes for
dihydrolipoyl
succinyltransferase (dlst).
a Integrated genetic and
physical map of the ste locus.
The ste mutation interval is
flanked by the microsatellite
markers z13385 and z381 and
encodes two open reading
frames, zebrafish dlst and prox2.
b Within the coding sequence of
zdlst a point mutation (G?A)
was identified at the splice
donor site of intron 5 leading to
aberrant pre-mRNA splicing
and the premature termination
of DLST translation. An arrow
marks the mutated base. c,
d Spatial expression of dlst by
whole-mount antisense RNA
in situ hybridization of wt and
ste-/- embryos at 72 hpf. c dlst
is ubiquitously expressed with
pronounced levels in the brain,
skeletal muscle, fins and heart
of wild-type embryos.
d Strongly reduced dlst mRNA
levels in ste-/- mutants
compared to wild-type
littermates. e Quantitative real-
time PCR of ste-/- mutants and
wild-type siblings. Nonsense
mediated dlst-RNA decay in
ste-/- mutants compared to
wild-type siblings at 72 hpf
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Morpholino-modified antisense oligonucleotides to inacti-
vate their function. When co-injecting 10.4 ng Morpho-
lino-modified antisense oligonucleotides targeting the
splice site of exon 5 of subunit E1a (MO-E1a) and 5.4 ng
of MO-E1b targeting the splice site of exon 7 of subunit
E1b into zebrafish wild-type embryos, 93 % (n = 40) of
the injected embryos displayed significantly reduced heart
rates at 72 hpf (100 ± 6 bpm, in controls 133 ± 2 bpm,
n = 10, p \ 0.0001) similar to homozygous ste-/- mutant
embryos (Fig. 4e). Similarly, after injection of 21.2 ng of
Morpholino-modified antisense oligonucleotide directed to
the splice site of exon 3 of subunit E3 (MO-E3), severe
bradycardia with 90 ± 7 bpm could be observed in 89 %
(n = 18) of the injected embryos at 72 hpf, indicating that
indeed loss of the a-ketoglutarate dehydrogenase complex
activity of the citric acid cycle accounts for bradycardia in
ste-/- mutants (Fig. 4e).
Finally, to evaluate whether basal heart rate is regulated
via the citric acid cycle or merely the a-ketoglutarate
dehydrogenase complex, we blocked the citric acid cycle
Fig. 3 Targeted knockdown of
zdlst phenocopies the ste-/-
mutant phenotype. a,





the ste mutant phenotype (b),
whereas injection of the same
amount of standard control
Morpholino (MO-control)
(c) does not impact on heart
rate. d Similar to ste-/-




at 72 hpf. e, f Transmission
electron microscopy (TEM) of
wild-type and ste-/- ventricular
myocardium at 72 hpf. Scale
bar represents 3 lM. e In wild-
type myocardium, mitochondria
display regular structure of
inner and outer membrane and
cristae. f In ste-/- myocardium,
mitochondria display
derangement of structure with
severely reduced numbers of
cristae. g, h TEM of wild-type
and ste-/- skeletal muscle at
72 hpf. Scale bar represents
1 lM. g In wild-type skeletal
muscle mitochondria exhibit
regular morphology. h In ste-/-
skeletal muscle mitochondria
are characterized by large
vacuoles and reduced numbers
of cristae
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by a pharmacological approach independent of the a-
ketoglutarate dehydrogenase complex. To do so, we
inhibited aconitate hydratase and thereby efficiently citric
acid cycle function by sodiumfluoroacetate (SFA) [36].
After incubation of 24 hpf zebrafish wild-type embryos for
48 h in 0.2 mg/ml SFA 83 % (n = 30) of the wild-type
embryos exhibit similar to ste-/- mutants bradycardia with
an average heart rate of 78 ± 3 bpm compared to
125 ± 3 bpm in controls (n = 11, p \ 0.0001). Remark-
ably, incubation of wild-type embryos in much lower doses
of SFA (0.067 mg/ml) also impacts on heart rate, but with
a less pronounced effect (heart rate 97 ± 3 bpm and
125 ± 3 bpm in controls; n = 11, p \ 0.0001, Fig. 4e),
demonstrating a dose-dependent effect of citric acid cycle
inhibition on zebrafish heart rate. In summary, these find-
ings indicate an essential role of the citric acid cycle in
zebrafish heart rate control.
Reduced ATP levels lead to cardiac dysfunction
in ste-/- mutant zebrafish
The citric acid cycle is an essential metabolic process that
ensures energy delivery under normoxic conditions. Within
the citric acid cycle GTP (guanine-tri-phosphate), NADH
(reduced nicotinamide adenine dinucleotide) and FADH2
(reduced flavin adenine dinucleotide) are produced and
ultimately converted to ATP by the respiratory chain reac-
tion [13]. Hence, to evaluate the impact of loss of DLST
function on mitochondrial ATP production, we next mea-
sured ATP content in ste-/- mutants with a luciferase-based
assay. As depicted in Fig. 5a, we find severely reduced levels
of ATP in ste-/- mutants (34 ± 0.5 %, 75 ± 12 pmol) in
comparison to wild-type zebrafish embryos (218 ± 32 pmol,
n = 10, p = 0.0006) or wild-type ste siblings (86 ± 17 %,
188 ± 37 pmol, n = 10, p = 0.0096).
Fig. 4 Blockade of the citric acid cycle phenocopies the ste-/-
mutant phenotype. a–c, g Morpholino-modified antisense oligonu-
cleotide mediated knockdown of OGDH subunit E1 (MO-E1) (a) or
DLDH subunit E3 (MO-E3) (b) of the citric acid cycle phenocopies
the ste-/- bradycardia (g), whereas injection of a control Morpholino
has no effect (c, g). d–g Incubation of wild-type embryos with the
citric acid cycle blocker sodiumfluoroacetate (SFA) and the
respiratory chain uncoupler 2,4-dinitrophenol (DNP) phenocopies
the heart rate defect of ste-/- mutant embryos in a dose-dependent
manner
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To further evaluate if indeed reduction of ATP directly
accounts for bradycardia in ste-/- mutants, we next phar-
macologically inhibited ATP production by incubation
with 2,4-dinitrophenol (DNP) [8, 9, 46]. As shown in
Fig. 5a, we find an average reduction of ATP levels in
72 hpf wild-type zebrafish embryos incubated for 24 h in
10 lM DNP down to 26 % of the ATP content of wild-type
embryos (n = 10, p \ 0.0001) accompanied by severe
reduction of resting heart rate of DNP incubated embryos
down to 80 ± 4 bpm compared to 125 ± 3 bpm in con-
trols (n = 10, p \ 0.0001). To further prove that the effect
of loss of DLST on resting heart rate is mainly mediated
via ATP, we incubated ste-/- mutant zebrafish embryos
with the coenzyme Q10 analogue Idebenone (IDB), a
known enhancer of global mitochondrial function and ATP
production [6, 19]. As shown in Fig. 5b, incubation with
0.3 lM IDB leads to an increase of the resting heart rate of
ste-/- mutants from 81 ± 1.8 to 117 ± 2.1 bpm (n = 10,
p \ 0.0001), indicating partial rescue of bradycardia in
ste-/- mutants via enhanced mitochondrial function. In
summary, these findings implicate an essential role of
DLST for zebrafish heart rate control via ATP production.
Interestingly, as shown above, reduced ATP levels
mediated by loss of DLST function, seem not to directly
impact on ventricular cardiomyocyte contractile function,
since fractional shortening of ste-/- mutants is not reduced
under unstressed conditions, in comparison to the wild-type
siblings. Hence, to evaluate if enhancement of ATP con-
sumption might unmask the expected effect of ATP
reduction on cardiomyocyte contractile function, we next
raised the offspring of ste heterozygous embryos at an
increased temperature of 32 C [29, 32]. As shown in
Fig. 5 Reduced ATP levels in ste-/- mutants lead to sinus
bradycardia. a ATP content of ste-/- mutant embryos is significantly
reduced compared to wild-type embryos (TE strain) and wild-type ste
siblings (ste?/-;?/?), whereas ATP content between TE strain and
wild-type ste siblings does not significantly differ. Dead zebrafish
embryos serve as a control (72 hpf). The ATP content of embryos that
were incubated with SFA and DNP is also significantly reduced and
resembles the ATP content of ste-/- mutant embryos. b The
coenzyme Q10 analogue Idebenone partially rescues heart rate in
ste-/- mutant embryos that were incubated with this drug. c ste-/-
mutants were incubated at increased temperature throughout embryo-
nic development and ventricular fractional shortening was measured
in wild-type and ste-/- mutant embryos at 72, 96 and 120 hpf.
Fractional shortening of ste-/- mutant embryos under normal
conditions (29 C) does not significantly differ compared to wild-
type embryos. Fractional shortening is reduced in ste-/- mutant
embryos raised at 32 C at (48 ± 2.1 vs. 54 ± 3.9 %, n = 10,
p = 0.0358), 96 hpf (18 ± 4.0 vs. 56 ± 2.0 %, n = 10, p \ 0.0001)
and 120 hpf (10 ± 3.5 vs. 56 ± 2.1 %, n = 10, p \ 0.0001)
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Fig. 5c, under normal rearing conditions of 29 C, ste-/-
mutant embryos exhibit preserved cardiac systolic function
throughout the first 5 days of embryonic development,
whereas raising the offspring at 32 C unmasks impaired
systolic ventricular function in ste-/- mutants. After
72 hpf ventricular fractional shortening is reduced to
48 ± 2.1 % in offspring raised at 32 C compared to
54 ± 1.7 % in ste-/- mutants raised at 29 C (n = 10,
p = 0.0358), at 96 hpf down to 18 ± 4.0 % compared to
58 ± 1.8 % (n = 10, p \ 0.0001) and at 120 hpf down to
9.9 ± 3.5 % compared to 51 ± 2.8 % (n = 10,
p \ 0.0001) in embryos raised at 29 C.
Loss of DLST leads to pacemaker cell dysfunction
in ste-/- mutant zebrafish
The observed reduced resting heart rate in ste-/- mutants
might be either caused by defective excitation generation in
the pacemaker site of the heart, the so-called sinus node, by
slowed-down myocardial excitation propagation in the
atrium and the ventricle, or by uncoupling of excitation and
contraction. To decipher the underlying pathophysiology of
ste-/- bradycardia, we next assayed cardiac calcium tran-
sients [23] and performed external electrical pacing experi-
ments. First, to evaluate if abnormal cardiac excitation
propagation or excitation–contraction coupling account for
the ste phenotype, we monitored free cytosolic myocardial
calcium and cardiac contraction simultaneously in ste-/-
mutant hearts at 72 hpf. As in wild-types, cardiac excitation
in ste-/- mutant embryos starts in the atrium, and then moves
from the atrium towards the ventricle. Each atrial calcium
wave is followed by a calcium wave through the ventricle
and each calcium wave is accompanied by cardiac chamber
contraction (n = 15/15, exemplary Supplementary Movie),
indicating that cardiac excitation in ste-/- mutants is cor-
rectly initiated in the atrium, but with a much lower fre-
quency compared to wild-types (Fig. 6a).
Next, to evaluate if either slowed excitation initiation in
the cardiac pacemaker cells, or a prolonged electrical
refractory period of cardiomyocytes underlies the ste bra-
dycardic phenotype, we performed selective cardiac sti-
mulation in ste-/- mutant embryos (Fig. 6b). As shown in
Fig. 6a, similar to the situation in wild-type hearts, selec-
tive electrical atrial stimulation above the endogenous
increases the heart rate in ste-/- mutants from around 80
up to 150 bpm (n = 15, exemplary Supplementary Movie),
whereby each atrial stimulation is followed by coordinated
sequential atrial and ventricular contractions. In summary,
these findings indicate that bradycardia in ste-/- mutants is
caused by defective excitation initiation in atrial pace-
maker cells, so-called sinus bradycardia, and not by
defective excitation propagation or excitation–contraction
uncoupling.
Discussion
In search for genetic regulators of the vertebrate heart
rate, we isolated in a large-scale mutagenesis screen the
bradycardic zebrafish mutant schneckentempo (ste) and
find here by positional cloning that loss of dihydrolipoyl
succinyltransferase (DLST) function leads to impaired
cardiac pacemaker function in ste-/- mutant embryos.
DLST is an essential component of the a-ketoglutarate
dehydrogenase complex of the citric acid cycle localized
in mitochondria, and hence involved in ATP production.
Accordingly, we find severely altered mitochondrial
morphology and reduced ATP levels in ste-/- mutant
zebrafish embryos, suggesting that limited energy supply
is the molecular cause for the observed bradycardia in
ste-/- mutants.
The essential role of regular ATP production and normal
ATP levels for heart rate regulation of the embryonic
zebrafish heart is further confirmed by the pharmacological
inhibition of ATP production with the citric acid cycle
blocker sodiumfluoroacetate SFA and the respiratory chain
reaction uncoupler dinitrophenol DNP. Incubation of wild-
type zebrafish embryos with either SFA or DNP sig-
nificantly reduces global ATP levels in the zebrafish
embryos as observed in the ste-/- zebrafish mutants and
causes reduced resting heart rates.
In contrast to this, resting heart rate in ste-/- mutants
can partially be rescued by incubation with the coenzyme
Q10 analogue Idebenone, which is known to promote ATP
production and improve mitochondrial function [6, 19],
thereby further confirming that the effect of loss of DLST
on resting heart rate is mainly mediated via ATP.
Cardiac calcium transient measurements and external
electrical pacing experiments reveal that under normal
conditions loss of DLST rather selectively impacts on
cardiac pacemaker cell function, whereas contractile force
is not significantly altered in ste-/- mutants, although ATP
levels are globally reduced. However, enhancement of
ATP consumption by rearing ste-/- mutants at higher
temperatures unmasks an impact of DLST also on ven-
tricular contractile function. DLST is known to catalyze
energy generation in the citric acid cycle in the mito-
chondrial matrix, where GTP, NADH and FADH2 are
produced. The energy equivalents NADH and FADH2 are
then converted to ATP in the respiratory chain complex in
the mitochondrial intermembrane space. Normally, this
oxidative phosphorylation accounts for more than 90 % of
the energy production of cells under normoxic conditions
[14, 17, 35, 43]. Patients suffering from reduced activity of
DLST develop lactate acidosis and usually die early during
childhood. Similar to ste-/- mutants, cardiac morphology
appears to be unaltered in DLST-deficient patients [5, 18,
26]. However, all reported cases in humans feature a
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residual DLST activity of 5–25 % [5, 18, 26]. By contrast,
we expect no residual activity of DLST in ste-/- mutant
zebrafish since translation of DLST is predicted to be
prematurely terminated and significant nonsense mediated
RNA decay of the mutated dlst transcript is observed in
ste-/- mutants.
Disorganization of the mitochondrial inner membrane
and deranged architecture of cristae are common in human
disorders featuring mitochondrial dysfunction [51]. Defi-
ciency of the citric acid cycle is known to increase pro-
duction of free radicals thereby inducing mitochondrial
damage [35]. Similar to the situation in humans [25], we
find severe alterations in mitochondrial morphology in the
hearts and skeletal muscle of ste-/- mutants with dis-
organization and increased mitochondrial density as well as
vacuoles within mitochondria and in their vicinity. The
ste-/- mitochondria exhibit an irregularly shape with
reduced cristae.
Interestingly, in a retrospective analysis of 90 patients
with inherited mitochondriopathies, 22.2 % exhibited car-
diac arrhythmias including sinus bradycardia [49]. ATP
levels are significantly reduced in ste-/- mutants to one-
third of the ATP content of wild-type zebrafish embryos. In
the DLST-deficient ste-/- mutant embryos ATP produc-
tion via oxidative phosphorylation is supposedly disrupted.
However, ATP can usually also be produced by alternative
pathways such as anaerobic glycolysis [14]. Furthermore,
ATP can be provided by maternally inherited mitochon-
dria. Similar to the situation in humans, maternal inheri-
tance of the mitochondrial DNA and passing on of
thousands of functionally active maternal mitochondria to
the embryo warrants oxidative phosphorylation during
zebrafish embryogenesis [3, 16, 41, 50]. Interestingly,
bradycardia in the ste-/- mutant zebrafish is first present at
72 hpf. At earlier developmental stages, we find no sig-
nificantly reduced heart rates in ste-/- mutant embryos,
suggesting that at these stages the residual ATP production
supposedly by maternal mitochondria is still sufficient to
maintain a normal heart rate.
There are three different possibilities how these reduced
ATP levels in ste-/- mutants might lead to bradycardia.
Reduced ATP levels could either impact on: (1) myofila-
ment activation, (2) excitability of the working myo-
cardium or (3) the depolarization of cardiac pacemaker
cells. However, we find here by external electrical stimu-
lation experiments and calcium transient analyses that
bradycardia in ste-/- mutants is not caused by prolonged
refractoriness of cardiomyocytes to excitation, or by
uncoupling of cardiomyocyte excitation–contraction, but
rather by reduced firing rates of the cardiac pacemaker
cells.
The pacemaker site of the zebrafish heart is localized in
the right dorsal quadrant of the atrium, near the inflow tract
of the atrium and the sinus venosus [2]. Tessadori et al.
[44] demonstrated that the pacemaker cells in zebrafish
resemble those in mammals in their gene expression pat-
tern and electrochemical properties, in particular their
ability to spontaneously depolarize. In mammals, a variety
of regulatory mechanisms exist to influence the action
potential frequency in sinus node cells [40, 48]. Pacemaker
cells in mammals depend strongly upon ATP to function
and to regulate their activity [48]. Yaniv et al. [48] recently
demonstrated that in pacemaker cells the ATP supply is
closely matched to the demand and is rapidly adjusted in
phases of high ATP demand. ATP is necessary for the
regulation of the action potential frequency in these cells
via the Ca2?–calmodulin activated adenylyl cyclase/pro-
teinkinase A, Ca2?–calmodulinkinase II, cAMP and Ca2?
Fig. 6 a Selective atrial
stimulation of ste-/- mutants at
72 hpf reconstitutes heart rate to
normofrequency as depicted by
simultaneous measurements of
atrial (blue) and ventricular
(green) cytoplasmic calcium
transients. b Schematic
description of the experimental
setup for selective atrial
stimulation using an electric
stimulator
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pathways. The reduced ATP levels in ste-/- mutants are
expected to impact on cAMP levels, since ATP is neces-
sary to activate adenylyl cyclase to produce cAMP [48].
Interestingly, absence of cAMP in cardiac pacemaker cells
is known to cause sinus bradycardia in mammals [40].
However, regular mitochondrial function not only warrants
ATP production and enables consecutive pathways such as
the cAMP/Ca2? pathway, but is also crucial for various
other essential mechanisms and metabolic pathways in
mammals [1, 13]. Therefore, other ATP-independent
mechanisms apart from reduced ATP levels might partially
contribute to cardiac dysfunction in ste-/- mutant zebrafish
embryos, since the ste-/- mutants’ mitochondrial function
and structure is severely disrupted. Mitochondria are both
an essential source of ROS as well as an important target of
injury by ROS [25, 39]. Therefore, mitochondriopathies are
often accompanied by enhanced ROS production causing
further mitochondrial damage and leading to cell damage
and inducing apoptosis [25, 39]. Similarly, increased ROS
production and its consecutive injury to cells due to loss of
mitochondrial DLST function possibly contribute to car-
diac dysfunction in ste-/- mutants and thereby impact on
heart rate regulation.
In search for novel genetic heart rate regulators den
Hoed and co-workers recently conducted a GWAS meta-
analysis and linked 14 chromosomal loci to heart rate
regulation [12]. Interestingly, one of the associated loci
contains DLST. Hence, thorough genetic analysis might
reveal a modifying or even causal role of DLST gene
variants in the pathogenesis of cardiac pacemaker diseases,
such as the sick sinus syndrome.
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